Solexa Announces Technical Milestones at the AGBT Conference
News Feb 10, 2006
Solexa, Inc. has announced a number of significant technical advances that highlight the potential of the Solexa Genome Analysis System to transform DNA sequencing and expression profiling.
The presented data provides evidence of the Company’s progress in extending the capabilities of its system to handle a broad range of sequencing applications.
Speaking at the 2006 Advances in Genome Biology and Technology Conference (AGBT), Dr. David Bentley, chief scientist of Solexa, presented data on the Company’s progress in achieving higher raw read accuracy, longer read lengths and paired reads.
He further discussed data that demonstrates the feasibility of using the Solexa Genome Analysis System for resequencing of entire genomes, of candidate and linkage regions and of genes, as well as provided preliminary results from Solexa’s Genome Initiative, the Company’s stated goal to resequence a human genome in 2006.
"The data presented today speaks to the enormous technical progress we have made in recent months, and indicates that we could access a wider segment of the sequencing market and accelerate the adoption rate of the system," stated John West, chief executive officer of Solexa.
"We expect these impressive achievements to enhance the ability of scientists to rapidly and economically resequence genomes using the Solexa Genome Analysis system, and to extend the system’s capabilities to perform true de novo sequencing and other specialized sequencing applications."
The Company also announced its commitment to release data generated from a variety of projects, including Solexa’s Genome Initiative, at regular intervals.
The data, which will include sequence traces as well as aligned reads, will be made available through a browser developed in collaboration with Ensembl.
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019